1. Home
  2. BMEA vs RTC Comparison

BMEA vs RTC Comparison

Compare BMEA & RTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMEA
  • RTC
  • Stock Information
  • Founded
  • BMEA 2017
  • RTC 2003
  • Country
  • BMEA United States
  • RTC China
  • Employees
  • BMEA N/A
  • RTC N/A
  • Industry
  • BMEA Biotechnology: Pharmaceutical Preparations
  • RTC Specialty Chemicals
  • Sector
  • BMEA Health Care
  • RTC Industrials
  • Exchange
  • BMEA Nasdaq
  • RTC Nasdaq
  • Market Cap
  • BMEA 153.3M
  • RTC 180.6M
  • IPO Year
  • BMEA 2021
  • RTC N/A
  • Fundamental
  • Price
  • BMEA $4.19
  • RTC $3.25
  • Analyst Decision
  • BMEA Buy
  • RTC
  • Analyst Count
  • BMEA 13
  • RTC 0
  • Target Price
  • BMEA $37.25
  • RTC N/A
  • AVG Volume (30 Days)
  • BMEA 1.1M
  • RTC 38.5K
  • Earning Date
  • BMEA 10-29-2024
  • RTC 01-14-2025
  • Dividend Yield
  • BMEA N/A
  • RTC N/A
  • EPS Growth
  • BMEA N/A
  • RTC N/A
  • EPS
  • BMEA N/A
  • RTC N/A
  • Revenue
  • BMEA N/A
  • RTC $59,794,661.00
  • Revenue This Year
  • BMEA N/A
  • RTC N/A
  • Revenue Next Year
  • BMEA N/A
  • RTC N/A
  • P/E Ratio
  • BMEA N/A
  • RTC N/A
  • Revenue Growth
  • BMEA N/A
  • RTC N/A
  • 52 Week Low
  • BMEA $3.61
  • RTC $2.48
  • 52 Week High
  • BMEA $20.21
  • RTC $40.00
  • Technical
  • Relative Strength Index (RSI)
  • BMEA 24.17
  • RTC 11.77
  • Support Level
  • BMEA $3.81
  • RTC $3.08
  • Resistance Level
  • BMEA $6.06
  • RTC $4.30
  • Average True Range (ATR)
  • BMEA 0.56
  • RTC 0.73
  • MACD
  • BMEA -0.14
  • RTC -0.55
  • Stochastic Oscillator
  • BMEA 7.40
  • RTC 2.34

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.

About RTC Baijiayun Group Ltd.

Baijiayun Group Ltd is a ToB video cloud technology service provider that solves various pain points and needs in the field of video technology applications for enterprises. The group supplies energy for the digital development of enterprises through audio and video technology. The firm provides video technology solutions to enterprises and government agencies in various fields such as automobiles, finance, education, and medical care. Baijiayun has created three categories of product services namely video SaaS/PaaS business, video cloud products and software, and video system solutions. It has set up multiple R&D centers, branches, and offices across the country, enabling video technology to create industrial value and promote the development of the real economy.

Share on Social Networks: